Markets
95th Annual Academy Awards - Show
Elizabeth Banks and Cocaine Bear speak onstage during the 95th Annual Academy Awards (Kevin Winter/Getty Images)

US stocks stumble to start September with another day of AI names dumped

The S&P 500 ended down 0.7%, the Nasdaq 100 gave back 0.8%, and the Russell 2000 fell 0.6%.

Nia Warfield, Luke Kawa
9/2/25 3:41PM

The global sell-off in long-term government bonds weighed on risk assets on Tuesday, accentuating the pullback in the AI trade seen in the final trading day of August. However, stocks did manage to close at session highs after facing steep losses during the morning.

The S&P 500 ended down 0.7%, the Nasdaq 100 gave back 0.8%, and the Russell 2000 fell 0.6%.

A Morgan Stanley basket of AI tech beneficiaries is down 5.5% over the past two sessions, its worst two-day drubbing since the sessions immediately following “Liberation Day” on April 2, when the extent of President Donald Trump’s reciprocal tariff regime was unveiled.

Energy and healthcare were the only two S&P 500 sector ETFs to eke out gains, while tech was unsurprisingly at the bottom of the leaderboard.

The day’s bright spots were led by Ulta, which surged 8.1% as traders piled into the stock after the beauty retailer posted strong Q2 earnings on Friday. Kraft Heinz shares led declines, sinking 7% after the ketchup maker said it planned to split into two separate companies.

Nvidia dropped 2% amid a broad pullback in the AI trade as the chip giant’s newsroom pushed back on what it called “erroneous chatter in the media.”

CoreWeave sank 9.4% as its top shareholder, along with several executives, continued to take profits now that they’re finally allowed to sell.

Lucid shares fell 10.8%, hitting an all-time low on the first day that the luxury EV maker’s 1-for-10 reverse stock split took effect.

Constellation Brands dropped 6.6% after the beer giant slashed its full-year guidance, as the Modelo and Corona parent company braces for softer sales.

Canopy Growth fell 17.5% after the cannabis company filed for a $200 million equity offering on Friday, a move that would dilute existing shares and could put downward pressure on the stock.

Paramount Skydance dipped 1.6% after the production powerhouse announced a deal with Microsoft’s Activision to create a live-action “Call of Duty” film.

PepsiCo shares jumped as much as 5.9% before closing up 1.1% after The Wall Street Journal reported that Elliott Investment Management has taken an activist position of roughly $4 billion the company.

Nio rose 3.4% even as the Chinese EV company (and Tesla rival) posted a deeper net loss and lower revenue than Wall Street expected for the second quarter.

Frontier shares flew 14.5% higher after Deutsche Bank upgraded the stock to “buy” from “hold” following Friday’s news that rival Spirit Airlines had filed for its second bankruptcy in a year.

More Markets

See all Markets
markets

Robinhood, AppLovin, and Emcor pop on announcement of addition to S&P 500

Shares of Robinhood Markets, AppLovin, and Emcor are all rallying in post-market trading on Friday upon news that they’re being added to the S&P 500.

Shares of the brokerage popped 7.2%, the adtech company rose 7.8%, and the construction company was up a more modest 2.7% in the minutes following the announcement.

(Robinhood Markets, Inc. is the parent company of Sherwood Media, an independently operated media company subject to certain legal and regulatory restrictions.)

Strategy, another stock rumored to be in the running for inclusion in the benchmark US stock index that has been passed over, sank 2.5% in postmarket trading.

markets

Kenvue plunges after reports suggest RFK Jr. may try to link prenatal Tylenol use to autism

Kenvue sank 15% Friday after a WSJ report said Health and Human Services Secretary Robert F. Kennedy Jr. may attempt to link prenatal Tylenol use to autism in an upcoming government report.

Kenvue, the maker of Tylenol and formerly a division of Johnson & Johnson prior to a 2023 spin-out, pushed back, saying the science shows “no causal link” between acetaminophen use during pregnancy and autism, and pointed to FDA and medical groups that agree on the drug’s safety.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

markets

Lucid surges following 6 days of losses after headlines misidentify Cantor Fitzgerald’s lower split-adjusted price target as a good thing

It’s been a shortened week, but still a rough one for Lucid. Investor blowback to the luxury EV maker’s 1-for-10 reverse stock split has sent shares to all time lows this week.

After six straight days of closing lower, Wall Street appears to have decided enough is enough and is loading up on Lucid shares on Friday, sending them up 13% in recent trading. As of 2:10pm eastern, Lucid trading volumes were at more than 240% of their 30 day average.

Some of the move could be attributed to traders reading headlines that don’t take into consideration Lucid’s reverse split. Cantor Fitzgerald on Friday slapped a new price target on Lucid of $20, compared to its previous target of $3. Some news outlets (not us!) presented that as an increase. The problem: With the 1-for-10 reverse split in effect, a comparable price target would have been $30. The new $20 target is actually... a cut.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.